Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Differential escape mechanisms in cetuximab-resistant head and neck cancer cells.

Willey CD, Anderson JC, Trummell HQ, Naji F, de Wijn R, Yang ES, Bredel M, Thudi NK, Bonner JA.

Biochem Biophys Res Commun. 2019 Sep 10;517(1):36-42. doi: 10.1016/j.bbrc.2019.06.159. Epub 2019 Jul 13.

PMID:
31311651
2.

The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.

Lin VTG, Yang ES.

J Natl Cancer Inst. 2019 Jun 4. pii: djz114. doi: 10.1093/jnci/djz114. [Epub ahead of print]

PMID:
31165154
3.

Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans.

Jamshed H, Beyl RA, Della Manna DL, Yang ES, Ravussin E, Peterson CM.

Nutrients. 2019 May 30;11(6). pii: E1234. doi: 10.3390/nu11061234.

4.

The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors.

Miller AL, Fehling SC, Garcia PL, Gamblin TL, Council LN, van Waardenburg RCAM, Yang ES, Bradner JE, Yoon KJ.

EBioMedicine. 2019 Jun;44:419-430. doi: 10.1016/j.ebiom.2019.05.035. Epub 2019 May 22.

5.

WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.

Seifert ME, Gaut JP, Guo B, Jain S, Malone AF, Geraghty F, Della Manna DL, Yang ES, Yi N, Brennan DC, Mannon RB.

Am J Transplant. 2019 Mar 27. doi: 10.1111/ajt.15372. [Epub ahead of print]

PMID:
30916889
6.

Targeting DNA repair in precision medicine.

Beggs R, Yang ES.

Adv Protein Chem Struct Biol. 2019;115:135-155. doi: 10.1016/bs.apcsb.2018.10.005. Epub 2018 Dec 5.

PMID:
30798930
7.

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial.

McDonald AM, Dobelbower MC, Yang ES, Clark GM, Jacob R, Kim RY, Cardan RA, Popple R, Nix JW, Rais-Bahrami S, Fiveash JB.

Adv Radiat Oncol. 2018 Sep 19;4(1):90-95. doi: 10.1016/j.adro.2018.09.007. eCollection 2019 Jan-Mar.

8.

Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.

Galgano SJ, Calderone CE, McDonald AM, Nix JW, deShazo M, Yang ES, McConathy JE, Rais-Bahrami S.

J Am Coll Radiol. 2019 Mar;16(3):315-320. doi: 10.1016/j.jacr.2018.09.026. Epub 2018 Nov 14. No abstract available.

PMID:
30447932
9.

The antitumor effects of entinostat in ovarian cancer require adaptive immunity.

Smith HJ, McCaw TR, Londono AI, Katre AA, Meza-Perez S, Yang ES, Forero A, Buchsbaum DJ, Randall TD, Straughn JM Jr, Norian LA, Arend RC.

Cancer. 2018 Dec 15;124(24):4657-4666. doi: 10.1002/cncr.31761. Epub 2018 Nov 13.

PMID:
30423192
10.

First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition.

Lin VTG, Nabell LM, Spencer SA, Carroll WR, Harada S, Yang ES.

J Natl Compr Canc Netw. 2018 Oct;16(10):1166-1170. doi: 10.6004/jnccn.2018.7056.

11.

Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case Examples.

Coker MA, Dulaney C, McDonald A, Nix JW, Gordetsky JB, Yang ES, Dobelbower MC, Rais-Bahrami S.

Cureus. 2018 Apr 24;10(4):e2524. doi: 10.7759/cureus.2524.

12.

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.

Arend RC, Londoño-Joshi AI, Gangrade A, Katre AA, Kurpad C, Li Y, Samant RS, Li PK, Landen CN, Yang ES, Hidalgo B, Alvarez RD, Straughn JM, Forero A, Buchsbaum DJ.

Oncotarget. 2018 Apr 10;9(27):19459. doi: 10.18632/oncotarget.25151. eCollection 2018 Apr 10.

13.

Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition.

Wielgos ME, Zhang Z, Rajbhandari R, Cooper TS, Zeng L, Forero A, Esteva FJ, Osborne CK, Schiff R, LoBuglio AF, Nozell SE, Yang ES.

Mol Cancer Ther. 2018 May;17(5):921-930. doi: 10.1158/1535-7163.MCT-17-0302. Epub 2018 Mar 28.

14.

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.

Arend RC, Londoño AI, Montgomery AM, Smith HJ, Dobbin ZC, Katre AA, Martinez A, Yang ES, Alvarez RD, Huh WK, Bevis KS, Straughn JM Jr, Estes JM, Novak L, Crossman DK, Cooper SJ, Landen CN, Leath CA 3rd.

Mol Cancer Res. 2018 May;16(5):813-824. doi: 10.1158/1541-7786.MCR-17-0594. Epub 2018 Mar 9.

15.

ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.

Chakraborty A, Dorsett KA, Trummell HQ, Yang ES, Oliver PG, Bonner JA, Buchsbaum DJ, Bellis SL.

J Biol Chem. 2018 Jan 19;293(3):984-994. doi: 10.1074/jbc.M117.808584. Epub 2017 Nov 30.

16.

JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma.

Garcia PL, Miller AL, Gamblin TL, Council LN, Christein JD, Arnoletti JP, Heslin MJ, Reddy S, Richardson JH, Cui X, van Waardenburg RCAM, Bradner JE, Yang ES, Yoon KJ.

Mol Cancer Ther. 2018 Jan;17(1):107-118. doi: 10.1158/1535-7163.MCT-16-0922. Epub 2017 Nov 15.

17.

DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy.

Dulaney CR, Rais-Bahrami S, Manna DD, Gordetsky JB, Nix JW, Yang ES.

Oncotarget. 2017 Jul 10;8(40):68038-68046. doi: 10.18632/oncotarget.19145. eCollection 2017 Sep 15.

18.

The Impact of DNA Repair Pathways in Cancer Biology and Therapy.

Nikolaev A, Yang ES.

Cancers (Basel). 2017 Sep 19;9(9). pii: E126. doi: 10.3390/cancers9090126.

19.

Implementation and utilization of the molecular tumor board to guide precision medicine.

Harada S, Arend R, Dai Q, Levesque JA, Winokur TS, Guo R, Heslin MJ, Nabell L, Nabors LB, Limdi NA, Roth KA, Partridge EE, Siegal GP, Yang ES.

Oncotarget. 2017 Jun 14;8(34):57845-57854. doi: 10.18632/oncotarget.18471. eCollection 2017 Aug 22. Review.

20.

Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.

Demark-Wahnefried W, Rais-Bahrami S, Desmond RA, Gordetsky JB, Hunter GR, Yang ES, Azrad M, Frugé AD, Tsuruta Y, Norian LA, Segal R, Grizzle WE.

Br J Cancer. 2017 Oct 24;117(9):1303-1313. doi: 10.1038/bjc.2017.303. Epub 2017 Sep 7.

Supplemental Content

Loading ...
Support Center